Emerging antibiotic resistance in urinary tract pathogens

被引：80

作者：

Gupta, K ^{[1
]}

机构：

[1] Univ Washington, Sch Med, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA

来源：

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2003年 / 17卷 / 02期

关键词：

D O I：

10.1016/S0891-5520(03)00006-0

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The most significant recent issues involving antimicrobial resistance in urinary tract infections (UTIs) include an increase in trimethoprim-sulfamethoxazole (TMP-SMX) resistance rates, specifically among community-acquired UTI isolates; correlation between in vitro susceptibility and clinical and bacteriologic outcomes in acute uncomplicated UTIs; and improved knowledge of the determinants of TMP-SMX resistance among uropathogenic Escherichia coli. This article focuses on these topics as well as the problems of emerging fluoroquinolone resistance and multi-drug resistance among community-acquired UTI isolates.

引用

页码：243 / +

页数：18

共 62 条

[1]

BAILEY RR, 1995, NEW ZEAL MED J, V108, P465

[2] Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain [J].

Barrett, SP ;

Savage, MA ;

Rebec, MP ;

Guyot, A ;

Andrews, N ;

Shrimpton, SB .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (03) :359-365

[3] Current microbiological and clinical aspects of urinary tract infections [J].

Bonadio, M ;

Meini, M ;

Spitaleri, R ;

Gigli, C .

EUROPEAN UROLOGY, 2001, 40 (04) :439-444

[4] A European perspective on nosocomial urinary tract infections I.: Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study) [J].

Bouza, E ;

San Juan, R ;

Muñoz, P ;

Voss, A ;

Kluytmans, J .

CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (10) :523-531

[5] Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan [J].

Brown, PD ;

Freeman, A ;

Foxman, B .

CLINICAL INFECTIOUS DISEASES, 2002, 34 (08) :1061-1066

[6] Ciprofloxacin-resistant Escherichia coli emerging in a rehabilitation medical center [J].

Canawati, HN ;

ElFarra, R ;

Seymour, J ;

Shimashita, J ;

Dunn, D ;

Montgomerie, JZ .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1997, 29 (03) :133-138

[7]

CANAWATI HN, 2002, 102 ANN C AM SOC MIC

[8] Correlation between increased consumption of fluoroquinolones in outpatients and resistance of Escherichia coli from urinary tract infections [J].

Cizman, M ;

Orazem, A ;

Krizan-Hergouth, V ;

Kolman, J .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (04) :502-502

[9] Antimicrobial susceptibility of community-acquired uropathogens in northern Israel [J].

Colodner, R ;

Keness, Y ;

Chazan, B ;

Raz, R .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 18 (02) :189-192

[10] Extended spectrum beta-lactamase production and fluorquinolone resistance in pathogens associated with community acquired urinary tract infection [J].

Cormican, M ;

Morris, D ;

Corbett-Feeeney, G ;

Flynn, J .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 32 (04) :317-319

← 1 2 3 4 5 6 7 →